or
forgot password
  • cancer clinical trials in pascagoula, MS

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Prostate Cancer
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Endometrial Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer, Pulmonary Complications, Radiation Fibrosis
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Brain and Central Nervous System Tumors
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Head and Neck Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Endometrial Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Singing River Hospital
    Pascagoula, Mississippi 39581
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Colorectal Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Colorectal Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Endometrial Cancer, Fatigue, Neurotoxicity
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Lung Cancer
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Head and Neck Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Singing River Hospital
    Pascagoula, Mississippi 39581
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Brain and Central Nervous System Tumors
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Brain and Central Nervous System Tumors
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Cervical Cancer, Endometrial Cancer, Sarcoma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Regional Cancer Center at Singing River Hospital
    Pascagoula, Mississippi 39581
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity